Rhinacanthus nasutus (L.) KURZ (Acanthaceae) is a shrub widely distributed in South China and India. In this study, the antiproliferative activity of the ethanol extract of root and aqueous extract of leaves of R. nasutus, and the supposed active moiety rhinacanthin C was assessed in vitro using the human cervical carcinoma cell line HeLa, its MDR1-overexpressing subline Hvr100-6, human prostate carcinoma PC-3 cells and human bladder carcinoma T24 cells. Rhinacanthin C was chemically synthesized and its content in the R. nasutus extracts was determined by HPLC with a photodiode array detector. The antiproliferative activity of the R. nasutus extracts was also assessed in vivo using sarcoma 180-bearing mice. It was suggested that 1) the in vitro antiproliferative activity of rhinacanthin C was comparable with or slightly weaker than that of 5-FU, 2) rhinacanthin C showed antiproliferative activity for MDR1-overexpressing Hvr100-6 cells, similarly to parent HeLa cells, 3) the in vitro antiproliferative activity of the ethanol extract of root R. nasutus was due to rhinacanthin C, whereas that of the aqueous extract of leaves of R. nasutus was due to constituents other than rhinacanthin C, and 4) both of the R. nasutus extracts showed in vivo antiproliferative activity after oral administration once daily for 14 d.
Rhinacanthus nasutus (L.) KURZ (Acanthaceae), a shrub widely distributed in South China and India, has been recently cultivated for use in the treatment of hepatitis, diabetes, hypertension and skin diseases in Taiwan. 1, 2) Indigenous medical practitioners use the roots and leaves pounded with vinegar or alcohol. 1, 2) Among various compounds isolated from R. nasutus, including flavonoids, anthraquinones, triterpenes, and sterols, naphthoquinones have shown some biological activity. [1] [2] [3] To date, 14 naphthoquinone derivatives have been isolated and named rhinacanthin A-D and G-P. [1] [2] [3] Although there is little information on their biological activity, rhinacanthin C and D have been demonstrated to show antiviral activity, being comparable with gancyclovir and acyclovir. 1) During the assay for antiviral activity, they were also found to show cytotoxicity. 1) In this study, the antiproliferative activity of the ethanol extract of root and aqueous extract of leaves of R. nasutus was assessed in vitro and in vivo. The human cervical carcinoma cell line HeLa-Ohio (HeLa) and its multidrug resistant subline, Hvr100-6, [4] [5] [6] [7] and the human prostate carcinoma cell line PC-3 and human bladder carcinoma cell line T24 were used for in vitro assessment. The information of antiproliferative activity of new agents on prostate and bladder carcinoma cells could be useful because benefit of chemotherapy has been limited. 8, 9) In vivo antiproliferative activity of the R. nasutus extracts was evaluated after oral administration once daily for 14 d using murine sarcoma 180-bearing ICR mice. Herein, rhinacanthin C was chemically synthesized by a new route for future structure-activity relationship investigations with the 2-hydroxy-1,4-naphthoquinone moiety as a key structure (Figs. 1,  2) . The amount of rhinacanthin C was determined by HPLC with a photodiode array detector, and its in vitro antiproliferative activity was also evaluated and compared with that of the R. nasutus extracts to elucidate whether rhinacanthin C was the main constituent for antiproliferative activity.
MATERIALS AND METHODS

Materials
Both of the R. nasutus extracts, the ethanol extract of root and aqueous extract of leaves, were kindly supplied by ARSOA HONSHA Corp. (Yamanashi). Rhinacanthin C was synthesized as described below. Vinblastine sulfate (VLB), paclitaxel (TXL), doxorubicin hydrochloride (DXR), daunorubicin hydrochloride (DNR), 5-fluorouracil (5-FU), and mitomycin C (MMC) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka). Cisplatin (CDDP) was from Sigma-Aldrich Chemical Co. (St. Louis, MO, U.S.A.). Other chemicals were of the highest purity available.
Synthesis of Rhinacanthin C The first total synthesis of rhinacanthin C has been achieved and reported by Awai et al. 10) In the present study, we planned the route of synthesis by considering the preparation of a 2-hydroxy-1,4-naphthoquinone moiety as a key structure to carry out structure-activity relationship investigations in the future (Figs. 1, 2 ). We adopted a convergent route to prepare a suitable precursor (I), which could be converted to rhinacanthin C by demethylation and air oxidation at the final step, by condensing with a stable 1,2,4-trimethoxynaphthalene derivative (II) having a hydroxyl group, and the olefin-containing conjugated carboxylic acid side chain (III). Thus we selected the 3-substituted-1,2,4-trimethoxynaphthalene derivative (II) as a suitable candidate for the stable 2-hydroxy-1,4-naphthoquinone precursor. Starting with 1,2,4-trimethoxynaphthalene (1), a methoxycarbonyl group was introduced by the metalationsubstitution reaction in high yield. Reduction by lithium aluminum hydride (LAH) and bromination afforded 3-bromomethyl-1,2,4-trimethoxynaphthalene (4), which was treated with ethyl isobutyrate in the presence of lithium diisopropylamide to give a-dimethylcarboxylic acid ester (5). Subsequent reduction by LAH gave a desired precursor (II) in 81% yield from 5. On the other hand, the synthesis of monoterpene carboxylic acid (III) was achieved by using 4-methyltrans-4-hexenal (8) according to a previous report. 10) 4-Methyl-trans-4-hexenal (8) was prepared by Swern oxidation of 4-methyl-trans-4-hexenol (CH 3 CHϭC(CH 3 )CH 2 CH 2 CH 2 -OH) (7) which was synthesized originally, by the carbon-carbon bond forming reaction of 2-lithio-cis-2-butene and Osilylated 3-bromopropanol. The derived silyl ether (6) was exposed to tetrabutylammonium fluoride (TBAF) to afford a known alcohol (7) in 81%. Both intermediates II and III were condensed with the help of water-soluble carbodiimide to afford the desired precursor (I) in a good yield (60%). The final demethylation by BBr 3 and subsequent air oxidation afforded rhinacanthin C in 65% yield only in the presence of 2-methyl-2-butene in the reaction mixture to avoid undesirable bromination at the olefin function. The structures of all compounds and synthetic rhinacanthin C were confirmed mainly on the basis of NMR spectral data and mass spectroscopic analysis (see Appendix).
Determination of Rhinacanthin C Content in R. nasutus Extracts by HPLC with a Photodiode Array Detector The rhinacanthin C content of the R. nasutus extracts was determined by HPLC with a photodiode array detector. The HPLC apparatus consisted of a pump (LC-10A, Shimadzu Co., Kyoto, Japan) equipped with a photodiode array detector (SPD-M10Avp, Shimadzu Co.) and a workstation (CLASS LC10/M10A, Shimadzu Co.). The column was CAPCELL PAK C18 UG80 (4.6 mmϫ250 mm, Shiseido Co., Ltd., Tokyo). The mobile phase consisted of acetonitrile : double distilled water : trifluoroacetic acid at a volume ratio of 80 : 20 : 0.1. The flow rate was 1.0 ml/min, and the column temperature was maintained at 40°C. Ten or 15 ml of aqueous solution of the R. nasutus extracts was injected onto the chromatograph, and the peak areas at 254 nm and 10.7 min were used for quantification after comparing the absorption spectrum with that of rhinacanthin C. The rhinacanthin C content of the ethanol extract of root and aqueous extract of leaves of R. nasutus was determined as the average of 3 experiments, and the CV% was 0.022% and 0.067%, respectively.
Cell Culture of HeLa, Hvr100-6, PC-3 and T24 for in Vitro Assessment HeLa cells were obtained from Dainippon Pharmaceutical Co., Ltd. (Osaka, Japan). They were maintained in culture medium consisting of Dulbecco's modified Eagle's medium (D-MEM with glucose (4.5 g/l), L-glutamine (4 mM) and sodium pyruvate (1 mM tively, and PC-3 and T24 cells were seeded in culture dishes (IWAKI No. 3020-100, ASAHI TECHNO GLASS Corp., Chiba, Japan) at a density of 2 and 1ϫ10 6 cells/100 mm dish, respectively, grown in a humidified atmosphere of 5% CO 2 -95% air at 37°C, and subcultured every 3 or 4 d with 0.05% trypsin-0.02% EDTA (Invitrogen Corp.).
In Vitro Antiproliferative Activity of R. nasutus Extracts and Rhinacanthin C The in vitro antiproliferative activity of the R. nasutus extracts and rhinacanthin C was assessed by the WST-1 (tetrazolium salts) colorimetric assay using a Cell Counting Kit (Dojindo Laboratories, Kumamoto, Japan). Cells (1000 cells/well) were seeded on 96-well plates ("Nunclon" flasks, Nalge Nunc International, Rochester, NY, U.S.A.) in 100 ml of culture medium on Day 0, and the culture medium was exchanged for that containing test material at various concentrations on Day 1. After incubation for 3 d at 37°C (on Day 4), the culture medium was exchanged for 110 ml of that containing WST-1 reagent solution (10 ml of WST-1 solution and 100 ml of the culture medium), and 3 h later, the absorbance was determined at 450 nm with a reference wavelength of 630 nm using a microplate reader (SJeia Auto Reader II; Sanko Junyaku Co. Ltd., Tokyo, Japan). The 50% growth inhibitory concentration (IC 50 ) was calculated according to the sigmoid inhibitory effect model as follows using the nonlinear least-squares fitting method ("WinNonlin", ver. 2.1, Pharsight Corp., Mountain View, CA, U.S.A.):
E and E max represent the surviving fraction (% of control) and its maximum, respectively, and C and g represent the drug concentration in the medium and the sigmoidicity factor, respectively. Each series of experiments was conducted in quadruplicate.
In Vivo Antiproliferative Activity of R. nasutus Extracts The in vivo antiproliferative activity of the R. nasutus extracts was also assessed using sarcoma 180-bearing mice. Sarcoma 180 was kindly supplied by the National Cancer Center, Japan, and maintained by the weekly transplantation of ascites, 1ϫ10 6 cells/0.1 ml, into the peritoneal cavity of recipient male 5-6 week old ICR mice (CREA JAPAN, Inc., Tokyo, Japan). A cell suspension of sarcoma 180 was transplanted into the right femoral muscle at a concentration of 1ϫ10 6 cells/0.1 ml on day 0, and the R. nasutus extracts were given orally once daily at a dose of 500 mg/kg/d from day Ϫ7 to day Ϫ1 and day 1 to day 7 (total of 14 d). To check the validity of in vivo experimental system, antiproliferative activity of MMC was also assessed in sarcoma 180-bearing mouse. MMC was given intraperitoneally once daily at a dose of 1 mg/kg/d from day 1 to day 7 (for 7 d). The dosing volume was 0.1 ml per 10 g weight of mice. On day 10, the mice were sacrificed, and the antiproliferative activity was assessed as the inhibition rate (%); IR (%)ϭ[1Ϫ(tumor weight of treatment group)/(tumor weight of untreated group)]ϫ100.
Statistical Analysis The data represent the meanϮstan-dard deviation (S.D.) or standard error (S.E.). Multiple comparisons were performed using one-way analysis of variance (ANOVA) followed by Scheffé F-test. p values of less than 0.05 (two-tailed) were considered significant. Figure 3 shows typical chromatograms after injection of the aqueous solution of the R. nasutus extracts. By comparison of absorption spectrum and quantification based on the peak areas, rhinacanthin C content was found to be 0.474 and 0.0017 (w/w)% for the ethanol extract of root and aqueous extract of leaves of R. nasutus, respectively.
RESULTS
Rhinacanthin C Content of R. nasutus Extracts
In Vitro Antiproliferative Activity of R. nasutus Extracts and Rhinacanthin C Table 1 lists the IC 50 values for the R. nasutus extracts and rhinacanthin C in HeLa and its MDR1-overexpressing subline, Hvr100-6. The ethanol extract of root showed similar cytotoxicity in HeLa and Hvr100-6 cells, as did the aqueous extract of leaves. Rhinacanthin C showed IC 50 values of 26.2Ϯ4.08 mM and 11.2Ϯ 4.21 mM, respectively, and these were comparable with or slightly weaker than those of 5-FU. Table 2 lists the IC 50 values for PC-3 and T24 cells. The R. nasutus extracts and rhinacanthin C showed higher cytotoxicity for these cells than HeLa and Hvr100-6 cells. The IC 50 values of rhinacanthin C 1072
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Fig. 3. Typical HPLC Chromatograms of Ethanol Extract of Root of R. nasutus (A) and Aqueous Extract of Leaves of R. nasutus (B)
Based on the peaks indicated by arrows, the rhinacanthin C content of the ethanol extract of root and aqueous extract of leaves of R. nasutus was determined to be 0.474. In Vivo Antiproliferative Activity of R. nasutus Extracts The in vivo antiproliferative activity of the R. nasutus extracts was assessed using sarcoma 180-bearing mice. Table 3 lists the tumor weight with or without treatment using the R. nasutus extracts (p.o., 500 mg/kg/d for 14 d) or MMC (i.p., 1 mg/kg/d for 7 d). The activity of MMC was found, showing that this sarcoma 180-bearing mouse system is appropriate to assess the activity of rhinacanthin C. The ethanol extract of root and aqueous extract of leaves of R. nasutus showed significant antiproliferative activity with inhibition of 52.5% and 44.2%, respectively.
DISCUSSION
Fourteen naphthoquinone derivatives isolated from R. nasutus are classified into 4 dimethyldihydropyrano-1,4-naphthoquinones (rhinacanthin A, B, O and P) and 10 2-hydroxyl-1,4-naphthoquinones (rhinacanthin C, D, G-N). [1] [2] [3] Rhinacanthin C and D were isolated by anti murine cytomegalovirus (mCMV) activity-guided fractionation, and their antiviral activity has been studied extensively using the viral cytopathic effect (CPE) assay, the plaque-neutralization (plaque) assay, and the hemadsorption-inhibition (HAI) assay. In the CPE assay or plaque assay using mCMV, it has been demonstrated that rhinacanthin C shows cytotoxicity, but rhinacanthin D has weaker cytotoxicity, suggesting that rhinacanthin C might be a promising candidate for development as a novel anticancer drug. The reason for the difference of activity is still unknown, but lipophilicity could contribute to the cytotoxicity. 3, 10) This study was conducted to assess the antiproliferative activity of rhinacanthin C as an anticancer drug and to know the potential of other constituents. It has been suggested that rhinacanthin C shows antiproliferative activity, being comparable with or slightly weaker than 5-FU. Here, the rhinacanthin C content of the ethanol extract of root of R. nasutus was determined to be 0.474 (w/w)%. Thus, rhinacanthin C should be included at concentrations of 14.3 mM and 11.3 mM in solutions of 1239 mg/ml and 977 mg/ml (the IC 50 values in HeLa and Hvr100-6 cells, respectively (Table 1) ) of the ethanol extract of root, and these rhinacanthin C concentrations were comparable with the IC 50 values, that is, 26.2 mM and 11.2 mM, respectively, suggesting that most of the antiproliferative activity of the ethanol extract of root in these cells was due to rhinacanthin C. In contrast, the rhinacanthin C content of the aqueous extract of leaves of R. nasutus was only 0.0017 (w/w)%, and the antiproliferative activity of the aqueous extract of leaves in HeLa and Hvr100-6 cells was due to other components than rhinacanthin C.
R. nasutus extracts and rhinacanthin C showed similar in vitro antiproliferative activity both for HeLa and for Hvr100-6 cells. Hvr100-6 cells are a MDR1-overexpressing HeLa subline. Multidrug resistance is one of the most serious causes of the failure of chemotherapy, and biological factors in multidrug resistance have been investigated, including down-regulation of the uptake or induction of efflux systems (e.g., MDR1), induction of inactivation enzymes, alteration of targeted enzymes, changes in DNA repair processes, and alteration of apoptotic signaling.
11) MDR1 expression is the best characterized of these mechanisms, and the magnitude of resistance depends on the expression of MDR1 up-regulated by chemotherapy. Using HeLa and Hvr100-6 cells, it has already been demonstrated that the antiproliferative activity of anthracyclines, vinca-alkaloids, taxanes, actinomycin D and etoposide decreased extensively according to the MDR1 expression. R. nasutus extracts and rhinacanthin C might be effective for tumors with multidrug resistance acquired by chemotherapy.
R. nasutus extracts and rhinacanthin C exhibited in vitro antiproliferative activity on PC-3 and T24, which are human prostate and bladder carcinoma cell lines, respectively. Addition to radiotherapy or surgery, androgen deprivation therapy and chemotherapy has been used in patients with prostate cancer. However, chemotherapy has failed to demonstrate a survival benefit in clinical trials of hormone refractory disease, though is has resulted in clinical benefit in some studies. 8) While chemotherapy for bladder cancer has been used after surgery, the effect was limited.
9) The information on antiproliferative activity of novel agents on prostate and bladder carcinoma cells could be useful for the discovery of new chemotherapeutic agents.
R. nasutus extracts showed in vivo antiproliferative activity ( Table 3 ). The once daily oral administration of 500 mg/kg/d of the ethanol extract of root and aqueous extract of leaves of R. nasutus for 14 d resulted in suppression of sarcoma 180 growth in mice by 52.5% and 44.2%, respectively. As for the ethanol extract of root of R. nasutus, this is equivalent to 2.37 mg/kg/d of rhinacanthin C. Rhinacanthin C has a molecular weight of 411, which is comparable with that of oral drugs, suggesting that the in vivo antiproliferative activity of the ethanol extract of root of R. nasutus was due to rhinacanthin C transferred into the blood circulation.
In summary, the antiproliferative activity of the ethanol extract of root and aqueous extract of leaves of R. nasutus, and its supposed active moiety rhinacanthin C was assessed in vitro using HeLa, its MDR1-overexpressing subline Hvr100-6, PC-3 and T24, and in vivo activity was also assessed using sarcoma 180-bearing mice. It was suggested that 1) the in vitro antiproliferative activity of rhinacanthin C was comparable with or slightly weaker than that of 5-FU, 2) rhinacanthin C showed antiproliferative activity for MDR1-overexpressing Hvr100-6 cells, similarily to parent HeLa cells, 3) the in vitro antiproliferative activity of the ethanol extract of root R. nasutus was due to rhinacanthin C, whereas that of the aqueous extract of leaves of R. nasutus was due to other compounds than rhinacanthin C, and 4) both of the R. nasutus extracts showed in vivo antiproliferative activity after oral administration once daily for 14 d. 
APPENDIX
